|1.||Toledo-Pereyra, Luis H: 2 articles (03/2007 - 09/2006)|
|2.||Calvey, Colleen R: 1 article (03/2007)|
|3.||Romano, Suzanne J: 1 article (09/2006)|
|4.||Lopez-Neblina, Fernando: 1 article (09/2006)|
|5.||Ward, Peter A: 1 article (09/2006)|
|6.||Lentsch, Alex B: 1 article (09/2006)|
|7.||Anaya-Prado, Roberto: 1 article (09/2006)|
03/01/2007 - "TB-1269 and OC-229 are two of the most promising of inhibitors in this class - they are capable of binding all three selectins, they have been demonstrated to reduce neutrophil infiltration following ischemia/reperfusion, and they have been associated with reduced tissue damage in experimental animal models of ischemia/reperfusion involving the liver, the heart, the kidneys, and the whole body. "
09/01/2006 - "Mice subjected to 90 min of partial (70-80%) hepatic ischemia and 3 h of reperfusion were divided into three groups (n = 9/group): sham, ischemic control, and treated group, which received 25 mg/kg of the anti-selectin small molecule OC-229. "
|2.||salicylhydroxamic acid (SHAM)